FDA — authorised 28 March 2006
- Application: NDA021980
- Marketing authorisation holder: ALCON LABS INC
- Status: supplemented
FDA authorised Fluorescite on 28 March 2006
Yes. FDA authorised it on 28 March 2006; FDA has authorised it.
ALCON LABS INC holds the US marketing authorisation.